Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析

◆英語タイトル:Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH15267FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Evonik Industries AG (EVK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemical company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including agriculture, renewable energies, paints and coatings, paper and printings, metal and oil products, electrical and electronics food and animal feed, consumer and personal care products, pharmaceuticals, plastics and rubber, automotive and construction. It also offers process technology, technical, logistics, utilities and waste management, and engineering services. Evonik has major production facilities in Germany, Belgium, the US, China, and Singapore. The company has operations in North America, Asia-Pacific, Africa, South America, Europe and others. Evonik is headquartered in Essen, Nordrhein-Westfalen, Germany.

Evonik Industries AG Key Recent Developments

Mar 19,2021: Evonik and InnovationLab bring new battery technology to the market
Mar 10,2021: Evonik launches solutions to improve the performance and safety of electric vehicle batteries in China
Mar 09,2021: GET H2: New alliance aims to create the basis of a European infrastructure for green hydrogen
Feb 11,2021: Evonik strengthens strategic partnership with Biontech on covid-19 vaccine
Feb 11,2021: Evonik converts PU a dditives stabilizer portfolio to sustainable low VOC formulations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Evonik Industries AG – Key Facts
Evonik Industries AG – Key Employees
Evonik Industries AG – Key Employee Biographies
Evonik Industries AG – Major Products and Services
Evonik Industries AG – History
Evonik Industries AG – Company Statement
Evonik Industries AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Evonik Industries AG – Business Description
Business Segment: Nutrition & Care
Overview
Performance
Business Segment: Performance Materials
Overview
Performance
Business Segment: Services
Overview
Performance
Business Segment: Smart Materials
Overview
Performance
Business Segment: Specialty Additives
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Central & South America
Performance
Geographical Segment: Europe, Middle East & Africa
Performance
Geographical Segment: North America
Performance
R&D Overview
Evonik Industries AG – Corporate Strategy
Evonik Industries AG – SWOT Analysis
SWOT Analysis – Overview
Evonik Industries AG – Strengths
Evonik Industries AG – Weaknesses
Evonik Industries AG – Opportunities
Evonik Industries AG – Threats
Evonik Industries AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Evonik Industries AG, Petrochemicals, Deals By Year, 2015 to YTD 2021
Evonik Industries AG, Petrochemicals, Deals By Type, 2015 to YTD 2021
Evonik Industries AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 19, 2021: Evonik and InnovationLab bring new battery technology to the market
Mar 10, 2021: Evonik launches solutions to improve the performance and safety of electric vehicle batteries in China
Mar 09, 2021: GET H2: New alliance aims to create the basis of a European infrastructure for green hydrogen
Feb 11, 2021: Evonik strengthens strategic partnership with Biontech on covid-19 vaccine
Feb 11, 2021: Evonik converts PU a dditives stabilizer portfolio to sustainable low VOC formulations
Jan 11, 2021: Evonik begins marketing of natural refrigerants
Dec 09, 2020: Evonik’s Venture Capital unit buys minority stake in Chinese firm UnionTech
Nov 12, 2020: Extracting hydrogen from natural gas networks: Linde and Evonik offer joint technology solution
Oct 27, 2020: Evonik launches EUDRAGIT ready-to-use powder premix to improve processing, appearance and swallowability of oral drug products with an immediate release profile
Oct 15, 2020: Evonik delivers Q3 adjusted EBITDA of €519 million above market expectations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Evonik Industries AG, Key Facts
Evonik Industries AG, Key Employees
Evonik Industries AG, Key Employee Biographies
Evonik Industries AG, Major Products and Services
Evonik Industries AG, History
Evonik Industries AG, Subsidiaries
Evonik Industries AG, Joint Venture
Evonik Industries AG, Key Competitors
Evonik Industries AG, Ratios based on current share price
Evonik Industries AG, Annual Ratios
Evonik Industries AG, Annual Ratios (Cont...1)
Evonik Industries AG, Annual Ratios (Cont...2)
Evonik Industries AG, Interim Ratios
Evonik Industries AG, Petrochemicals, Deals By Year, 2015 to YTD 2021
Evonik Industries AG, Petrochemicals, Deals By Type, 2015 to YTD 2021
Evonik Industries AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):企業の財務・戦略的SWOT分析
    Xinjiang Goldwind Science & Technology Co Ltd (002202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • W&T Offshore Inc (WTI):企業の財務・戦略的SWOT分析
    W&T Offshore Inc (WTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Nestle Australia Ltd:企業の戦略・SWOT・財務情報
    Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ceylon Cold Stores PLC:企業の戦略・SWOT・財務情報
    Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report Summary Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hitachi Zosen Corp (7004):電力:M&Aディール及び事業提携情報
    Summary Hitachi Zosen Corp (Hitz) is an industrial and engineering company. It designs, constructs and operates refuse incineration and recycling facilities, pressure vessels, marine diesel engines, and press machines, and other process machine. The company also provides after-sales servicing and ma …
  • Otsuka Pharmaceutical Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Inform Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …
  • ICON Plc (ICLR):製薬・医療:M&Aディール及び事業提携情報
    Summary ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • OP Financial Group:企業の戦略・SWOT・財務分析
    OP Financial Group - Strategy, SWOT and Corporate Finance Report Summary OP Financial Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • HCA Healthcare Inc (HCA):製薬・医療:M&Aディール及び事業提携情報
    Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and an …
  • Nissin Foods Holdings Co Ltd (2897):企業の財務・戦略的SWOT分析
    Nissin Foods Holdings Co Ltd (2897) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Golden Valley Mines Ltd. (GZZ):企業の財務・戦略的SWOT分析
    Golden Valley Mines Ltd. (GZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Keryx Biopharmaceuticals Inc (KERX)-製薬・医療分野:企業M&A・提携分析
    Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease. The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Au …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Future Retail Limited (FRL):企業の財務・戦略的SWOT分析
    Future Retail Limited (FRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • gel-e Inc:製品パイプライン分析
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc is a medical device company that offers products for the treatment of acute wounds. The company's products include spray foams, bandages, gels, films, and band-aids. It offers proprietary technology platform that helps in development of w …
  • Opiant Pharmaceuticals Inc (OPNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Dentsply Sirona Inc (XRAY)-医療機器分野:企業M&A・提携分析
    Summary Dentsply Sirona Inc (Dentsply) formerly Dentsply International Inc. is a medical device company that designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic instrumen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆